BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32943494)

  • 41. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage.
    Oravecz T; Pall M; Roderiquez G; Gorrell MD; Ditto M; Nguyen NY; Boykins R; Unsworth E; Norcross MA
    J Exp Med; 1997 Dec; 186(11):1865-72. PubMed ID: 9382885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
    Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
    J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A natural CCL5/RANTES variant antagonist for CCR1 and CCR3.
    Capoulade-Métay C; Ayouba A; Kfutwah A; Lole K; Pêtres S; Dudoit Y; Deterre P; Menu E; Barré-Sinoussi F; Debré P; Theodorou I
    Immunogenetics; 2006 Jul; 58(7):533-41. PubMed ID: 16791620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tails of the unexpected - an atypical receptor for the chemokine RANTES/CCL5 expressed in brain.
    Pease JE
    Br J Pharmacol; 2006 Nov; 149(5):460-2. PubMed ID: 17001302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of structure, dynamics, and detergent interactions of the anti-HIV chemokine variant 5P12-RANTES.
    Wiktor M; Hartley O; Grzesiek S
    Biophys J; 2013 Dec; 105(11):2586-97. PubMed ID: 24314089
    [TBL] [Abstract][Full Text] [Related]  

  • 46. beta-Arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1.
    van Der Lee MM; Bras M; van Koppen CJ; Zaman GJ
    J Biomol Screen; 2008 Dec; 13(10):986-98. PubMed ID: 19036707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.
    Watts AO; Verkaar F; van der Lee MM; Timmerman CA; Kuijer M; van Offenbeek J; van Lith LH; Smit MJ; Leurs R; Zaman GJ; Vischer HF
    J Biol Chem; 2013 Mar; 288(10):7169-81. PubMed ID: 23341447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5.
    Olson WC; Rabut GE; Nagashima KA; Tran DN; Anselma DJ; Monard SP; Segal JP; Thompson DA; Kajumo F; Guo Y; Moore JP; Maddon PJ; Dragic T
    J Virol; 1999 May; 73(5):4145-55. PubMed ID: 10196311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines.
    Hartley O; Dorgham K; Perez-Bercoff D; Cerini F; Heimann A; Gaertner H; Offord RE; Pancino G; Debré P; Gorochov G
    J Virol; 2003 Jun; 77(12):6637-44. PubMed ID: 12767983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different effects of the different natural CC chemokine receptor 2b ligands on beta-arrestin recruitment, Gαi signaling, and receptor internalization.
    Berchiche YA; Gravel S; Pelletier ME; St-Onge G; Heveker N
    Mol Pharmacol; 2011 Mar; 79(3):488-98. PubMed ID: 21088225
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA).
    Aggarwal A; Agarwal S; Misra R
    Clin Exp Immunol; 2007 Jun; 148(3):515-9. PubMed ID: 17374135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
    Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential intracellular expression of CCR5 and chemokines in multiple sclerosis subtypes.
    Jalonen TO; Pulkkinen K; Ukkonen M; Saarela M; Elovaara I
    J Neurol; 2002 May; 249(5):576-83. PubMed ID: 12021948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
    Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
    J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Effect of N-Terminal Cyclization on the Function of the HIV Entry Inhibitor 5P12-RANTES.
    F Nguyen A; S Schill M; Jian M; J LiWang P
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28726743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: a model system to examine the role of chemokines in cell function.
    Sarau HM; Rush JA; Foley JJ; Brawner ME; Schmidt DB; White JR; Barnette MS
    J Pharmacol Exp Ther; 1997 Oct; 283(1):411-8. PubMed ID: 9336350
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro.
    Maeda K; Nakata H; Koh Y; Miyakawa T; Ogata H; Takaoka Y; Shibayama S; Sagawa K; Fukushima D; Moravek J; Koyanagi Y; Mitsuya H
    J Virol; 2004 Aug; 78(16):8654-62. PubMed ID: 15280474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation.
    Kara E; Crépieux P; Gauthier C; Martinat N; Piketty V; Guillou F; Reiter E
    Mol Endocrinol; 2006 Nov; 20(11):3014-26. PubMed ID: 16887887
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Partial Agonist and Biased Signaling Properties of the Synthetic Enantiomers J113863/UCB35625 at Chemokine Receptors CCR2 and CCR5.
    Corbisier J; Huszagh A; Galés C; Parmentier M; Springael JY
    J Biol Chem; 2017 Jan; 292(2):575-584. PubMed ID: 27895119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CCL2/CCR2, but not CCL5/CCR5, mediates monocyte recruitment, inflammation and cartilage destruction in osteoarthritis.
    Raghu H; Lepus CM; Wang Q; Wong HH; Lingampalli N; Oliviero F; Punzi L; Giori NJ; Goodman SB; Chu CR; Sokolove JB; Robinson WH
    Ann Rheum Dis; 2017 May; 76(5):914-922. PubMed ID: 27965260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.